Close



Apr 2, 2024 07:00AM
Mar 7, 2024 07:00AM
Mar 4, 2024 07:03AM
Mar 4, 2024 07:00AM
Feb 4, 2024 09:03AM
Feb 3, 2024 04:20PM
Jan 10, 2024 07:00AM EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
Dec 4, 2023 07:01AM
Dec 4, 2023 07:00AM
Mar 27, 2023 07:00AM
Mar 20, 2023 07:00AM
Mar 2, 2023 07:00AM
Feb 27, 2023 07:00AM
Feb 27, 2023 07:00AM EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Del
Feb 27, 2023 07:00AM
Jan 23, 2023 07:10AM
Jan 23, 2023 07:00AM
Jan 5, 2023 07:00AM
Jan 4, 2023 07:00AM
Nov 2, 2022 07:00AM
Sep 29, 2022 07:00AM EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 PAVIA Clinical Trial of EYP-1901 for the Treatment of Non-Proliferative Diabetic Retinopathy
Aug 3, 2022 07:00AM
Aug 1, 2022 07:00AM
Jul 18, 2022 07:30AM
Jul 15, 2022 08:57AM
Jul 15, 2022 08:57AM
Jun 21, 2022 07:02AM
Jun 21, 2022 07:00AM EyePoint Pharmaceuticals and OcuMension Therapeutics Announce Approval of New Drug Application by China’s NMPA for YUTIQ® for the Treatment of Chronic Non-Infectious Uveitis Affecting the Posterior
May 4, 2022 07:30AM
Mar 7, 2022 07:00AM
Mar 3, 2022 07:00AM
Feb 14, 2022 05:40AM
Feb 12, 2022 08:10AM
Nov 3, 2021 07:00AM
Nov 1, 2021 07:04AM EyePoint Pharmaceuticals (EYPT) Appoints Jay S. Duker, M.D. as Chief Operating Officer
Nov 1, 2021 07:00AM
Oct 12, 2021 03:00PM
Oct 12, 2021 03:00PM
Sep 17, 2021 07:00AM
Aug 4, 2021 07:00AM
Aug 2, 2021 07:00AM
Jul 20, 2021 07:00AM EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®
Jul 6, 2021 07:04AM
Jul 6, 2021 07:00AM
Jul 1, 2021 07:03AM
Jul 1, 2021 07:00AM
Jun 28, 2021 07:00AM
May 25, 2021 07:02AM
May 25, 2021 07:00AM EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMD
May 5, 2021 07:00AM

377,103 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All